• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Inhibition of the replication of H9N2 influenza virus in vivo by short-term repeated oral administration of chicken interferon α

tetano

Editor, Senior Moderator
Sheng Wu Gong Cheng Xue Bao. 2019 Jun 25;35(6):1029-1040. doi: 10.13345/j.cjb.180490.
[h=1][Inhibition of the replication of H9N2 influenza virus in vivo by short-term repeated oral administration of chicken interferon α].[/h] [Article in Chinese; Abstract available in Chinese from the publisher]
Wang M[SUP]1,[/SUP][SUP]2[/SUP], Song J[SUP]1,[/SUP][SUP]2[/SUP], Fan W[SUP]1[/SUP], Liu L[SUP]1,[/SUP][SUP]2[/SUP], Huang Z[SUP]3[/SUP], Yang C[SUP]3[/SUP], Wu H[SUP]3[/SUP], Liu W[SUP]1,[/SUP][SUP]2[/SUP], Li J[SUP]1,[/SUP][SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] in English, Chinese
To evaluate the optimal administration frequency for interferon-α (IFN-α) and the effect of its combined use with inactive virus on chicken flocks, the prokaryotic expression plasmid pET-22b-ChIFN-α was constructed and transferred into Escherichia coli BL21(DE3) host bacteria to induce the expression of chicken IFN-α and to harvest recombinant proteins inclusion bodies. The expression of recombinant chicken IFN-α was confirmed by SDS-PAGE, and the results demonstrated that the chicken IFN-α (20 kDa) was highly expressed using the prokaryotic expression vector with a concentration of 0.2 mg/mL in the medium. Chicken IFN-α was diluted to 2.5?10⁴ U/fowls and administered to immunized specific-pathogen-free chickens orally in combination with inactivated H9N2 subtype influenza virus. Chicken that received chicken IFN-α were safe after three repeated immunizations (96 h). In addition, chicken IFN-α could induce higher levels of antiviral-related inducible genes in peripheral blood, spleen, and thymus of chicken flocks. The results of a challenge assay revealed that the lowest detoxification rates of chicken IFN-α ranged from three to five days, suggesting a higher capacity to resist H9N2 subtype avian influenza virus. The present study obtained the optimal immune frequency and immunization period for chicken IFN-α to provide theoretical support for the optimal clinical application of IFN-α.


[h=4]KEYWORDS:[/h] H9N2 influenza viruses; chicken interferon α; oral administration; short-term repeated

PMID: 31231999 DOI: 10.13345/j.cjb.180490
 
Back
Top Bottom